Accordingly, pharmacological blockade of C5aR1 in a syngeneic model of lung cancer impaired tumor growth, decreased the percentage of splenic MDSCs, and downregulated immunosuppression-related genes including ARG1, IL6, IL10, CTLA4, LAG3, and PDL1 within the tumor milieu (50). Here, C5AR1 is linked to neoplasm.